Bleeding and Thrombosis With Pediatric Extracorporeal Life Support: A Roadmap for Management, Research, and the Future From the Pediatric Cardiac Intensive Care Society: Part 2

Autor: Penk, Jamie S., Reddy, Sushma, Polito, Angelo, Cisco, Michael I, Allan, Catherine K., Bembea, Melania, Giglia, Therese M., Cheng, Henry H., Thiagarajan, Ravi R., Dalton, Heidi J.

Publikováno v: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol 20, iss 11
Pediatric Critical Care Medicine, Vol. 20, No 11 (2019) pp. 1034-1039
Pediatr Crit Care Med

OBJECTIVES: To make recommendations on improving understanding of bleeding and thrombosis with pediatric extracorporeal life support including future research directions. DATA SOURCES: Evaluation of literature and consensus conferences of pediatric c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4fdbc44c37770523bf7bbbd3bc1e0b76
https://escholarship.org/uc/item/46s72219

The Turkish experience with therapeutic plasma exchange: A national survey

Autor: Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, D

Therapeutic plasma exchange (TPE) is used to treat more than 60 diseases worldwide and has drawn growing interest. Little is known about the current situation of TPE activity in Turkey, so we developed a survey to obtain information about this timely

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3566::dad111e4dedad81046664d51e1e0e6a9

Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis

Autor: Helia Robert-Ebadi, Anne Rossel, Christophe Combescure, Olivier Grosgurin, Jérôme Stirnemann, Christophe Marti, Thomas Agoritsas, Alfredo Addeo, Jean-Luc Reny, Nicolas Garin

Publikováno v: PLoS ONE
PLOS ONE, Vol. 14, No 3 (2019) P. e0213940
PLoS ONE, Vol 14, Iss 3, p e0213940 (2019)

BackgroundLow-molecular-weight heparin (LMWH) is usually recommended for the treatment of cancer-associated thrombosis (CAT) but this treatment requires burdensome daily injections. We did a systematic review to compare the efficacy and safety of dir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de422a1be0fbd70771d04d3d9e058c1f
https://doi.org/10.1371/journal.pone.0213940

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial

Autor: Karine Provost, Gilles Pernod, Francis Couturaud, Philippe Castellant, Philippe Lorillon, Karine Lacut, Patrick Jego, Silvy Laporte, Elisabeth Duhamel, Jean-Luc Bosson, Patrick Mismetti, Christophe Leroyer, Claire Bal dit Sollier, Dominique Mottier, Pierre-Yves Salaun, Marie Guegan, Florence Parent, Philippe Girard, Michel Nonent, Emilie Presles, Hervé Decousus, Olivier Sanchez, Guy Meyer, Luc Bressollette

Publikováno v: Journal of the American Medical Association
Journal of the American Medical Association, American Medical Association (AMA), 2015, 314 (1), pp.31-40. ⟨10.1001/jama.2015.7046⟩
Journal of the American Medical Association, American Medical Association (AMA), 2015, 314 (1), pp.31-40. 〈10.1001/jama.2015.7046〉

International audience; The optimal duration of anticoagulation after a first episode of unprovoked pulmonary embolism is uncertain. To determine the benefits and harms of an additional 18-month treatment with warfarin vs placebo, after an initial 6-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e22969b36d471c32c48d9e0c9db234
https://hal.univ-brest.fr/hal-01259554

Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation:a register-based nested case-control study

Autor: Anton Pottegård, Line H.V. Holck, Jesper Hallas, Peter Martin Meegaard, René dePont Christensen, Hanne Madsen

Publikováno v: Pottegård, A, Meegaard, P M, Holck, L H, Christensen, R D, Madsen, H & Hallas, J 2013, ' Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation : a register-based nested case-control study ', European Journal of Clinical Pharmacology, vol. 69, no. 3, pp. 641-646 . https://doi.org/10.1007/s00228-012-1363-x

OBJECTIVES: The objective was to assess whether the concurrent use of tramadol and vitamin K antagonists (VKAs) leads to an increased risk of excessive anticoagulation. DESIGN: The study was designed as a case-control study, nested within users of VK

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c813ae497d185ba142be098f012f4b
https://portal.findresearcher.sdu.dk/da/publications/36113135-19bb-4ad3-9783-99c478790c07